AwardedCzechiaGoodsCZK 354,384,506
Léčivý přípravek CAR-T terapie - BREYANZI
- Published
- Published 24 July 2025
Overview
Předmětem plnění VZ jsou dodávky léčivého přípravku BREYANZI pro účely CAR-T terapie - Geneticky modifikovaná autologní buněčná imunoterapie cílená proti antigenu CD19 podávaná ke snížení variability v definovaném poměru dávky CD8+ a CD4+ T- lymfocytů.
Key details
- Country
- Czechia
- Status
- Awarded
- Category
- Goods
- Estimated value
- CZK 354,384,506
- Procedure
- Direct
- Published
- 24 July 2025
Antineoplastic and immunomodulating agents
Award outcome
- Awarded value
- CZK 345,966,000
- Award date
- 2 June 2025
- Contract period
- 27 June 2025 → 6 June 2029
- Bristol-Myers Squibb spol. s r.o.
Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.
Notice history
Every published notice in this contracting process, newest first.
Contract Award Notice
24 July 2025
Contracting authority
Fakultní nemocnice Ostrava
Procuring entityOstrava, Czechia
Get the full picture
AI analysis, bid scoring, and expert strategy for this tender
Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.
See which competitors are winning the contracts you're chasing.
15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.